FARMINGDALE, N.Y.--(BUSINESS WIRE)--June 9, 2006--Enzo Biochem, Inc. (NYSE:ENZ - News), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, today reported operating results for the fiscal three and nine months ended April 30, 2006.
